The initial purpose of this study was to determine whether carvedilol, through activation of EGFR, can promote cancer. The results suggest that the cardiovascular drug carvedilol may be repurposed for skin cancer chemoprevention, but may not be an effective treatment of established tumors.

READ FULL ARTICLE Curated publisher From Mdlinx